Complete Filing Data
Elite Health Systems Inc. reported Net Income Loss of -$881.0 thousand for FY2021.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Elite Health Systems Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.1M | -$816.0K | -$881.0K | $533.0K | $142.0K | -$421.0K | $538.0K | $536.0K | $396.0K | $561.0K | -$667.0K | $729.0K | $29.0K | $469.0K | $72.0K | |
| Operating Income Loss | -$1.8M | -$765.0K | -$1.4M | -$88.0K | $1.6M | $1.5M | $131.0K | $688.0K | $614.0K | $544.0K | $736.0K | -$994.0K | $247.0K | $229.0K | $334.0K | $183.0K |
| Selling General And Administrative Expense | $1.8M | $765.0K | $1.4M | $1.1M | $1.2M | $1.2M | $1.3M | $1.3M | $1.3M | $1.2M | $1.2M | $994.0K | $1.0M | $947.0K | $979.0K | $878.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.2M | -$816.0K | -$1.5M | -$553.0K | $856.0K | $151.0K | -$613.0K | $441.0K | $878.0K | $648.0K | $803.0K | -$1.0M | $1.1M | $90.0K | -$60.0K | $72.0K |
| Income Loss From Equity Method Investments | -$434.0K | $25.0K | -$116.0K | -$19.0K | -$809.0K | -$1.4M | -$743.0K | -$101.0K | $638.0K | $285.0K | $14.0K | -$31.0K | $60.0K | $26.0K | -$40.0K | $0.00 |
| Operating Expenses | $765.0K | $1.4M | $1.1M | $1.6M | $1.6M | $3.3M | $2.7M | $2.6M | $2.4M | $1.9M | $994.0K | $1.7M | $1.8M | $1.6M | $1.3M | |
| Income Tax Expense Benefit | -$163.0K | $0.00 | $39.0K | $420.0K | $323.0K | $9.0K | -$192.0K | -$97.0K | $342.0K | $252.0K | $242.0K | -$362.0K | $362.0K | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.0K | $0.00 | $3.0K | $25.0K | $91.0K | $113.0K | $153.0K | $161.0K | $181.0K | $184.0K | $15.0K | $199.0K | $177.0K | $359.0K | $291.0K | |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $1.1M | $3.2M | $3.1M | $3.4M | $3.4M | ||||||||
| Health Care Organization Patient Service Revenue | $3.4M | $3.2M | $3.0M | $2.6M | $0.00 | $2.0M | $2.1M | $1.9M | $1.5M | |||||||
| Deferred Income Tax Expense Benefit | $0.00 | $0.00 | $17.0K | -$331.0K | -$361.0K | -$161.0K | $342.0K | $252.0K | $242.0K | -$362.0K | $362.0K | |||||
| Accrued Income Taxes Current | $166.0K | $171.0K | $414.0K | $111.0K | $220.0K | $0.00 | $64.0K | $0.00 | ||||||||
| Sales Type Lease Interest Income | $0.00 | $8.0K | $72.0K | $132.0K | $42.0K | |||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | -$235.0K | -$92.0K | $0.00 | ||||||||||||
| Nonoperating Income Expense | -$425.0K | -$51.0K | ||||||||||||||
| Other Nonoperating Income Expense | -$51.0K | -$147.0K | -$465.0K | -$759.0K | ||||||||||||
| Income Taxes Paid Net | $0.00 | $211.0K | $213.0K | $419.0K | $158.0K | $339.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 | Q1 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.2M | -$441.0K | -$424.0K | -$290.0K | -$432.0K | -$312.0K | -$127.0K | -$434.0K | -$108.0K | -$321.0K | -$1.1M | -$421.0K | -$352.0K | -$617.0K | $292.0K | $164.0K | $45.0K | $175.0K | $115.0K | -$59.0K | $186.0K | -$120.0K | $77.0K | $62.0K | $11.0K | $136.0K | $243.0K | $120.0K | $177.0K | $198.0K | $90.0K | $31.0K | $80.0K | $270.0K | $232.0K | -$106.0K | -$113.0K | -$188.0K | -$141.0K | $553.00 | $125.0K | -$11.0K | $62.0K | $128.00 | -$131.00 | $106.00 | -$74.00 | $86.00 | $55.00 | $395.00 | -$67.00 | |
| Operating Income Loss | -$1.2M | -$445.0K | -$427.0K | -$387.0K | -$437.0K | -$476.0K | -$151.0K | -$242.0K | -$130.0K | -$221.0K | -$292.0K | -$360.0K | -$268.0K | -$249.0K | $677.0K | $284.0K | $138.0K | $366.0K | $292.0K | $376.0K | $447.0K | $29.0K | $355.0K | $209.0K | $173.0K | $130.0K | $321.0K | $103.0K | $136.0K | $198.0K | $167.0K | $48.0K | $205.0K | $505.0K | $224.0K | -$259.0K | -$181.0K | -$322.0K | -$227.0K | -$54.00 | $151.0K | $39.0K | $111.0K | $29.00 | -$29.00 | $173.00 | $56.00 | $134.00 | $73.00 | $101.00 | $26.00 | |
| Selling General And Administrative Expense | $1.2M | $445.0K | $427.0K | $387.0K | $437.0K | $476.0K | $151.0K | $242.0K | $130.0K | $221.0K | $292.0K | $360.0K | $268.0K | $249.0K | $298.0K | $297.0K | $342.0K | $302.0K | $287.0K | $365.0K | $308.0K | $268.0K | $388.0K | $278.0K | $278.0K | $354.0K | $295.0K | $298.0K | $351.0K | $310.0K | $291.0K | $318.0K | $349.0K | $308.0K | $309.0K | $259.0K | $181.0K | $322.0K | $227.0K | $279.0K | $210.0K | $278.0K | $255.0K | $226.0K | $262.0K | $243.0K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.2M | -$441.0K | -$424.0K | -$290.0K | -$435.0K | -$475.0K | -$150.0K | -$511.0K | -$127.0K | -$377.0K | -$1.3M | -$493.0K | -$336.0K | -$385.0K | $544.0K | $239.0K | $60.0K | $233.0K | $167.0K | -$84.0K | $262.0K | -$101.0K | $170.0K | $148.0K | $32.0K | $223.0K | $392.0K | $203.0K | $282.0K | $316.0K | $143.0K | $50.0K | $128.0K | $440.0K | $232.0K | -$106.0K | -$182.0K | -$300.0K | -$225.0K | $125.0K | -$11.0K | $62.0K | ||||||||||
| Income Loss From Equity Method Investments | $0.00 | $2.0K | $2.0K | -$269.0K | $3.0K | -$156.0K | -$998.0K | -$133.0K | -$77.0K | -$135.0K | -$139.0K | -$56.0K | -$91.0K | -$146.0K | -$135.0K | -$470.0K | -$194.0K | -$151.0K | -$160.0K | -$30.0K | -$101.0K | $129.0K | $112.0K | $135.0K | $183.0K | $155.0K | $36.0K | $25.0K | -$36.0K | $8.0K | $27.0K | -$39.0K | -$3.0K | $19.0K | -$7.0K | $23.0K | $6.0K | -$21.0K | $0.00 | |||||||||||||
| Operating Expenses | $476.0K | $151.0K | $242.0K | $130.0K | $221.0K | $292.0K | $360.0K | $268.0K | $249.0K | $384.0K | $378.0K | $458.0K | $381.0K | $366.0K | $449.0K | $394.0K | $774.0K | $766.0K | $656.0K | $630.0K | $710.0K | $663.0K | $619.0K | $639.0K | $634.0K | $605.0K | $624.0K | $604.0K | $511.0K | $513.0K | $259.0K | $181.0K | $322.0K | $227.0K | $466.0K | $430.0K | $484.0K | $532.0K | $375.0K | $441.0K | $371.0K | |||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | -$163.0K | $0.00 | $0.00 | $0.00 | $1.0K | $1.0K | -$2.0K | $16.0K | $232.0K | $252.0K | $75.0K | $15.0K | $252.0K | $52.0K | -$25.0K | $76.0K | $19.0K | $93.0K | $86.0K | $21.0K | $87.0K | $149.0K | $83.0K | $105.0K | $118.0K | $53.0K | $19.0K | $48.0K | $170.0K | $0.00 | $0.00 | -$69.0K | -$112.0K | -$84.0K | $0.00 | $0.00 | $0.00 | |||||||||||||
| Interest Expense | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $2.0K | $5.0K | $7.0K | $11.0K | $21.0K | $25.0K | $29.0K | $25.0K | $28.0K | $32.0K | $40.0K | $36.0K | $41.0K | $34.0K | $39.0K | $41.0K | $47.0K | $36.0K | $54.0K | $73.0K | $52.0K | $13.0K | $5.0K | $0.00 | $0.00 | $53.0K | $57.0K | $59.0K | $70.0K | $67.0K | $69.0K | $87.0K | ||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.1M | $662.0K | $596.0K | $747.0K | $658.0K | $825.0K | $841.0K | $803.0K | $1.1M | $865.0K | $803.0K | $840.0K | ||||||||||||||||||||||||||
| Health Care Organization Patient Service Revenue | $865.0K | $803.0K | $840.0K | $984.0K | $722.0K | $775.0K | $832.0K | $772.0K | $672.0K | $809.0K | $1.0M | $737.0K | $0.00 | $0.00 | $0.00 | $0.00 | $275.00 | $617.0K | $469.0K | $595.0K | $513.00 | $503.00 | $548.00 | $496.00 | $507.00 | $548.00 | $472.00 | $389.00 | ||||||||||||||||||||||||
| Deferred Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$120.0K | $13.0K | -$244.0K | -$50.0K | $118.0K | $48.0K | $0.00 | -$84.0K | $0.00 | ||||||||||||||||||||||||||||||||||||||||
| Accrued Income Taxes Current | $0.00 | $0.00 | $0.00 | $170.0K | $170.0K | $170.0K | $231.0K | $231.0K | $403.0K | $197.0K | $190.0K | $116.0K | $72.0K | $435.0K | $399.0K | $616.0K | $389.0K | $394.0K | $400.0K | $413.0K | $200.0K | $98.0K | $92.0K | $0.00 | ||||||||||||||||||||||||||||
| Sales Type Lease Interest Income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $8.0K | $16.0K | $20.0K | $24.0K | $31.0K | $35.0K | $38.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$23.0K | -$77.0K | -$19.0K | -$57.0K | -$194.0K | -$74.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||
| Nonoperating Income Expense | $4.0K | $4.0K | $3.0K | $97.0K | $2.0K | $1.0K | $1.0K | -$269.0K | $3.0K | -$156.0K | -$998.0K | -$133.0K | -$68.0K | |||||||||||||||||||||||||||||||||||||||
| Other Nonoperating Income Expense | $0.00 | -$998.0K | -$133.0K | $9.0K | -$136.0K | -$133.0K | $0.00 | $0.00 | $0.00 | -$1.0K | $2.0K | $4.0K | -$13.0K | $13.0K | $13.0K | $0.00 | ||||||||||||||||||||||||||||||||||||
| Income Taxes Paid Net |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.2M | $645.0K | $1.2M | $2.6M | $3.7M | $3.2M | $3.0M | $3.4M | $2.9M | $2.4M | $2.0M | $1.4M | $2.1M | $1.3M | $1.3M | $839.0K | $765.0K |
| Cash And Cash Equivalents At Carrying Value | $466.0K | $1.5M | $2.2M | $2.0M | $1.3M | $1.5M | $2.7M | $2.0M | $1.1M | $1.1M | $1.4M | $1.5M | $830.0K | $820.0K | $673.0K | $605.0K | |
| Retained Earnings Accumulated Deficit | -$2.4M | -$1.7M | -$373.0K | $508.0K | -$25.0K | -$167.0K | $254.0K | -$284.0K | -$820.0K | -$1.2M | -$1.8M | -$1.1M | -$1.8M | -$1.9M | |||
| Other Assets Current | $61.0K | $18.0K | $65.0K | $99.0K | $102.0K | $154.0K | $67.0K | $71.0K | $98.0K | $72.0K | $30.0K | $33.0K | $7.0K | $19.0K | |||
| Liabilities And Stockholders Equity | $1.3M | $1.7M | $3.7M | $4.2M | $5.0M | $6.2M | $7.9M | $8.2M | $7.4M | $7.5M | $5.0M | $5.3M | $4.2M | $4.8M | |||
| Liabilities | $676.0K | $291.0K | $660.0K | $487.0K | $1.8M | $3.2M | $4.5M | $5.4M | $5.0M | $5.5M | $3.6M | $3.2M | $2.8M | $3.5M | |||
| Common Stock Value | $93.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $77.0K | |||
| Assets Current | $527.0K | $1.6M | $2.2M | $3.0M | $2.7M | $4.1M | $3.7M | $2.9M | $1.8M | $1.5M | $1.8M | $5.0M | $1.4M | $1.3M | |||
| Assets | $1.3M | $1.7M | $3.7M | $4.2M | $5.0M | $6.2M | $7.9M | $8.2M | $7.4M | $7.5M | $5.0M | $5.3M | $4.2M | $4.8M | |||
| Additional Paid In Capital Common Stock | $2.9M | $2.9M | $2.9M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | |||
| Accounts Payable And Accrued Liabilities Current | $59.0K | $86.0K | $169.0K | $170.0K | $255.0K | $227.0K | $208.0K | $86.0K | $80.0K | $96.0K | $154.0K | $67.0K | $24.0K | $113.0K | |||
| Liabilities Current | $607.0K | $280.0K | $626.0K | $410.0K | $1.6M | $1.9M | $1.6M | $1.5M | $1.3M | $1.1M | $419.0K | $2.9M | $563.0K | $736.0K | |||
| Property Plant And Equipment Net | $85.0K | $20.0K | $59.0K | $94.0K | $128.0K | $0.00 | $3.7M | $4.8M | $5.0M | $5.6M | $2.9M | $0.00 | $2.3M | $3.2M | |||
| Repayments Of Debt And Capital Lease Obligations | $0.00 | $0.00 | $89.0K | $901.0K | $1.4M | $1.1M | $1.0M | $1.0M | $803.0K | $340.0K | $2.3M | $431.0K | $766.0K | $902.0K | $647.0K | ||
| Equity Method Investments | $0.00 | $189.0K | $157.0K | $141.0K | $160.0K | $179.0K | $168.0K | $164.0K | $447.0K | $323.0K | $320.0K | $246.0K | $471.0K | $200.0K | |||
| Accounts Receivable Net Current | $0.00 | $346.0K | $356.0K | $318.0K | $767.0K | $891.0K | $626.0K | $277.0K | $0.00 | $7.0K | $313.0K | $421.0K | |||||
| Other Assets Noncurrent | $709.0K | $172.0K | $1.4M | $1.1M | $2.2M | $2.1M | $501.0K | $485.0K | $574.0K | $323.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.2M | $2.0M | $1.3M | $1.5M | $2.7M | ||||||||||||
| Operating Lease Right Of Use Asset | $85.0K | $20.0K | $59.0K | $94.0K | $128.0K | $0.00 | |||||||||||
| Operating Lease Liability Current | $27.0K | $23.0K | $43.0K | $40.0K | $36.0K | $0.00 | |||||||||||
| Operating Lease Liability Noncurrent | $58.0K | $0.00 | $23.0K | $66.0K | $106.0K | $0.00 | |||||||||||
| Equity Method Investment Dividends Or Distributions | $23.0K | $11.0K | $0.00 | $176.0K | $76.0K | $60.0K | $274.0K | $500.0K | $312.0K | $0.00 | |||||||
| Cash And Cash Equivalents Period Increase Decrease | -$1.2M | $722.0K | $894.0K | $15.0K | -$361.0K | -$36.0K | $620.0K | $10.0K | $147.0K | $68.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.6M | -$1.1M | -$641.0K | $148.0K | $695.0K | -$184.0K | -$1.2M | ||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $13.0K | $20.0K | $39.0K | $35.0K | $34.0K | $33.0K | $0.00 | ||||||||||
| Deferred Tax Liabilities Noncurrent | $675.0K | $591.0K | $303.0K | $150.0K | $0.00 | $362.0K | $0.00 | ||||||||||
| Notes And Loans Receivable Net Noncurrent | $0.00 | $38.0K | $38.0K | $38.0K | $38.0K | $210.0K | $0.00 | ||||||||||
| Accounts Receivable Related Parties Noncurrent | $930.0K | $912.0K | $1.4M | $0.00 | |||||||||||||
| Long Term Debt And Capital Lease Obligations Current | $821.0K | $265.0K | $2.3M | $539.0K | $623.0K | ||||||||||||
| Gain Loss On Sale Of Equity Investments | $0.00 | $237.0K | $0.00 | $24.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $5.0M | $3.8M | $4.2M | $4.2M | $3.7M | $2.0M | $333.0K | $645.0K | $570.0K | $698.0K | $1.1M | $735.0K | $1.1M | $2.2M | $3.3M | $3.7M | $4.2M | $3.5M | $3.4M | $3.3M | $3.3M | $3.1M | $3.2M | $3.5M | $3.6M | $3.5M | $3.3M | $3.3M | $3.1M | $2.9M | $2.7M | $2.6M | $2.2M | $2.1M | $2.0M | $1.8M | $1.5M | $1.3M | $1.6M | $1.7M | $1.9M | $1.5M | $1.4M | $1.4M | $1.3M | ||||||
| Cash And Cash Equivalents At Carrying Value | $4.0M | $3.1M | $3.7M | $4.0M | $3.2M | $2.2M | $1.8M | $559.0K | $776.0K | $1.3M | $651.0K | $1.1M | $1.7M | $2.6M | $2.8M | $2.5M | $1.5M | $2.0M | $1.7M | $1.4M | $1.6M | $1.4M | $1.6M | $2.3M | $2.3M | $3.6M | $3.7M | $3.4M | $2.3M | $2.2M | $1.5M | $1.1M | $1.3M | $1.1M | $1.3M | $1.1M | $1.7M | $1.5M | $1.6M | $1.9M | $929.0K | $956.0K | $1.0M | $817.0K | $1.0M | $575.0K | $942.0K | ||||
| Retained Earnings Accumulated Deficit | -$6.5M | -$5.3M | -$4.9M | -$4.4M | -$3.4M | -$3.1M | -$2.7M | -$2.4M | -$2.3M | -$1.8M | -$2.2M | -$1.9M | -$794.0K | $130.0K | $473.0K | $1.0M | $359.0K | $195.0K | $150.0K | $75.0K | -$40.0K | $19.0K | $273.0K | $393.0K | $316.0K | $106.0K | $95.0K | -$41.0K | -$325.0K | -$445.0K | -$622.0K | -$1.0M | -$1.1M | -$1.1M | -$1.4M | -$1.7M | -$1.9M | -$1.6M | -$1.4M | -$1.3M | -$1.7M | -$1.8M | -$1.8M | -$1.8M | |||||||
| Other Assets Current | $302.0K | $40.0K | $33.0K | $28.0K | $18.0K | $46.0K | $56.0K | $20.0K | $30.0K | $19.0K | $52.0K | $57.0K | $47.0K | $67.0K | $89.0K | $80.0K | $94.0K | $98.0K | $96.0K | $234.0K | $200.0K | $159.0K | $174.0K | $187.0K | $251.0K | $73.0K | $96.0K | $62.0K | $137.0K | $80.0K | $82.0K | $60.0K | $81.0K | $50.0K | $79.0K | $31.0K | $27.0K | $101.0K | $84.0K | $47.0K | $23.0K | $13.0K | $19.0K | $81.0K | |||||||
| Liabilities And Stockholders Equity | $5.3M | $4.0M | $4.3M | $4.3M | $3.8M | $3.0M | $2.6M | $871.0K | $1.0M | $1.6M | $1.2M | $1.7M | $3.2M | $3.8M | $4.1M | $4.6M | $4.4M | $5.1M | $5.3M | $5.4M | $5.9M | $6.7M | $8.2M | $7.9M | $8.2M | $8.2M | $8.8M | $8.9M | $8.4M | $7.9M | $7.7M | $7.2M | $7.8M | $8.0M | $7.6M | $7.4M | $2.6M | $2.3M | $2.6M | $2.8M | $4.0M | $3.9M | $4.2M | $4.5M | |||||||
| Liabilities | $291.0K | $197.0K | $91.0K | $143.0K | $143.0K | $1.0M | $2.3M | $202.0K | $188.0K | $258.0K | $347.0K | $417.0K | $647.0K | $464.0K | $422.0K | $389.0K | $878.0K | $1.7M | $2.0M | $2.1M | $2.8M | $3.5M | $4.8M | $4.3M | $4.7M | $4.9M | $5.5M | $5.8M | $5.5M | $5.1M | $5.1M | $5.0M | $5.7M | $5.9M | $5.8M | $5.8M | $1.3M | $685.0K | $811.0K | $860.0K | $2.5M | $2.5M | $2.8M | $3.1M | |||||||
| Common Stock Value | $220.0K | $214.0K | $214.0K | $200.0K | $174.0K | $135.0K | $93.0K | $79.0K | $79.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $78.0K | $77.0K | |||||||
| Assets Current | $4.3M | $3.2M | $3.7M | $4.2M | $3.2M | $2.2M | $1.8M | $579.0K | $806.0K | $1.3M | $703.0K | $1.2M | $1.7M | $2.6M | $2.9M | $3.5M | $2.7M | $3.3M | $3.4M | $2.7M | $3.1M | $4.5M | $3.9M | $4.5M | $4.6M | $3.8M | $4.0M | $4.1M | $2.7M | $2.5M | $2.4M | $1.4M | $1.8M | $1.9M | $2.1M | $1.9M | $1.8M | $2.0M | $2.2M | $2.5M | $1.8M | $1.5M | $1.6M | $1.4M | |||||||
| Assets | $5.3M | $4.0M | $4.3M | $4.3M | $3.8M | $3.0M | $2.6M | $871.0K | $1.0M | $1.6M | $1.2M | $1.7M | $3.2M | $3.8M | $4.1M | $4.6M | $4.4M | $5.1M | $5.3M | $5.4M | $5.9M | $6.7M | $8.2M | $7.9M | $8.2M | $8.2M | $8.8M | $8.9M | $8.4M | $7.9M | $7.7M | $7.2M | $7.8M | $8.0M | $7.6M | $7.4M | $2.6M | $2.3M | $2.6M | $2.8M | $4.0M | $3.9M | $4.2M | $4.5M | |||||||
| Additional Paid In Capital Common Stock | $9.4M | $8.9M | $8.9M | $8.2M | $6.9M | $5.0M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M | |||||||
| Accounts Payable And Accrued Liabilities Current | $233.0K | $131.0K | $16.0K | $60.0K | $65.0K | $48.0K | $75.0K | $21.0K | $7.0K | $65.0K | $71.0K | $83.0K | $177.0K | $180.0K | $135.0K | $166.0K | $208.0K | $236.0K | $268.0K | $205.0K | $201.0K | $236.0K | $109.0K | $69.0K | $108.0K | $197.0K | $189.0K | $180.0K | $61.0K | $52.0K | $112.0K | $109.0K | $145.0K | $455.0K | $236.0K | $81.0K | $330.0K | $103.0K | $160.0K | $97.0K | $105.0K | $5.0K | $92.0K | $82.0K | |||||||
| Liabilities Current | $270.0K | $167.0K | $51.0K | $94.0K | $93.0K | $976.0K | $2.2M | $191.0K | $177.0K | $247.0K | $336.0K | $406.0K | $624.0K | $419.0K | $366.0K | $322.0K | $790.0K | $1.6M | $1.9M | $1.6M | $2.2M | $2.4M | $2.8M | $2.4M | $2.4M | $1.7M | $2.1M | $2.0M | $1.4M | $1.4M | $1.4M | $1.1M | $1.5M | $1.7M | $1.3M | $1.3M | $588.0K | $645.0K | $582.0K | $681.0K | $571.0K | $646.0K | $595.0K | ||||||||
| Property Plant And Equipment Net | $1.0M | $822.0K | $589.0K | $72.0K | $66.0K | $74.0K | $80.0K | $0.00 | $0.00 | $10.0K | $30.0K | $40.0K | $49.0K | $68.0K | $77.0K | $86.0K | $103.0K | $112.0K | $120.0K | $136.0K | $144.0K | $152.0K | $4.1M | $3.2M | $3.4M | $4.0M | $4.3M | $4.5M | $5.1M | $4.5M | $4.7M | $5.2M | $5.4M | $5.7M | $5.2M | $5.2M | $2.0M | $2.1M | $2.2M | $2.6M | |||||||||||
| Repayments Of Debt And Capital Lease Obligations | $0.00 | $0.00 | $89.0K | $370.0K | $318.0K | $257.0K | $250.0K | $292.0K | $147.0K | $0.00 | $2.3M | $131.0K | -$393.0K | ||||||||||||||||||||||||||||||||||||||
| Equity Method Investments | $22.0K | $193.0K | $191.0K | $187.0K | $185.0K | $137.0K | $152.0K | $150.0K | $146.0K | $152.0K | $164.0K | $161.0K | $276.0K | $250.0K | $222.0K | $248.0K | $213.0K | $211.0K | $173.0K | $164.0K | $164.0K | $395.0K | $364.0K | $428.0K | $384.0K | $338.0K | $303.0K | $295.0K | $331.0K | $265.0K | $308.0K | $239.0K | $283.0K | $330.0K | $324.0K | $433.0K | |||||||||||||||
| Accounts Receivable Net Current | $0.00 | $0.00 | $828.0K | $345.0K | $233.0K | $396.0K | $223.0K | $411.0K | $792.0K | $359.0K | $524.0K | $803.0K | $107.0K | $237.0K | $515.0K | $249.0K | $148.0K | $728.0K | $142.0K | $272.0K | $638.0K | $687.0K | $725.0K | $0.00 | $0.00 | $7.0K | $616.0K | $378.0K | $202.0K | $219.0K | |||||||||||||||||||||
| Other Assets Noncurrent | $0.00 | $0.00 | $547.0K | $717.0K | $714.0K | $292.0K | $201.0K | $277.0K | $476.0K | $466.0K | $1.4M | $1.1M | $1.1M | $1.1M | $1.6M | $1.6M | $1.8M | $2.5M | $2.7M | $2.0M | $211.0K | $202.0K | $202.0K | $393.0K | $435.0K | $319.0K | $547.0K | $833.0K | $605.0K | $638.0K | $594.0K | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.8M | $466.0K | $559.0K | $776.0K | $1.3M | $1.5M | $651.0K | $1.1M | $1.7M | $2.6M | $2.8M | $2.5M | $1.5M | $2.0M | $1.7M | $1.4M | $1.6M | $1.4M | $1.6M | $2.3M | $2.3M | ||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $46.0K | $55.0K | $63.0K | $72.0K | $66.0K | $74.0K | $80.0K | $0.00 | $0.00 | $10.0K | $30.0K | $40.0K | $49.0K | $68.0K | $77.0K | $86.0K | $103.0K | $112.0K | $120.0K | $136.0K | $144.0K | $152.0K | |||||||||||||||||||||||||||||
| Operating Lease Liability Current | $37.0K | $36.0K | $35.0K | $34.0K | $28.0K | $28.0K | $27.0K | $0.00 | $0.00 | $12.0K | $34.0K | $45.0K | $44.0K | $42.0K | $41.0K | $40.0K | $39.0K | $38.0K | $37.0K | $35.0K | $34.0K | $33.0K | |||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $10.0K | $19.0K | $29.0K | $38.0K | $39.0K | $47.0K | $54.0K | $0.00 | $12.0K | $0.00 | $0.00 | $12.0K | $34.0K | $45.0K | $56.0K | $77.0K | $87.0K | $97.0K | $115.0K | $125.0K | $134.0K | ||||||||||||||||||||||||||||||
| Equity Method Investment Dividends Or Distributions | $0.00 | $23.0K | $11.0K | $0.00 | $31.0K | $0.00 | $0.00 | $315.0K | $124.0K | $0.00 | |||||||||||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$418.0K | $1.5M | $412.0K | $51.0K | $283.0K | $454.0K | $213.0K | -$245.0K | |||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$338.0K | $1.3M | -$256.0K | -$520.0K | $513.0K | $399.0K | -$92.0K | -$418.0K | |||||||||||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $9.0K | $5.0K | $10.0K | $10.0K | $8.0K | $8.0K | $9.0K | ||||||||||||||||||||||||||||||||||||||||||||
| Deferred Tax Liabilities Noncurrent | $179.0K | $131.0K | $327.0K | $314.0K | $63.0K | $285.0K | $431.0K | $695.0K | $661.0K | $786.0K | $660.0K | $718.0K | $496.0K | $373.0K | $399.0K | $154.0K | $131.0K | $97.0K | $166.0K | $278.0K | |||||||||||||||||||||||||||||||
| Notes And Loans Receivable Net Noncurrent | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $38.0K | $210.0K | $210.0K | $210.0K | $210.0K | $210.0K | ||||||||||||||||||||||||||||||||||
| Accounts Receivable Related Parties Noncurrent | $140.0K | $15.0K | $9.0K | $1.0K | $965.0K | $918.0K | $923.0K | $916.0K | $1.2M | $1.2M | $1.4M | $1.4M | $1.4M | ||||||||||||||||||||||||||||||||||||||
| Long Term Debt And Capital Lease Obligations Current | $774.0K | $866.0K | $818.0K | $909.0K | $903.0K | $784.0K | $718.0K | $525.0K | $0.00 | $0.00 | $0.00 | $576.0K | $566.0K | $554.0K | $513.0K | ||||||||||||||||||||||||||||||||||||
| Gain Loss On Sale Of Equity Investments | $0.00 | $0.00 | $0.00 | $33.0K | $205.0K | $0.00 | $0.00 | $0.00 | $0.00 | $24.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $4.8M | $0.00 | $0.00 | -$89.0K | -$901.0K | -$1.4M | -$1.1M | -$1.0M | -$1.0M | -$803.0K | -$340.0K | -$2.3M | -$431.0K | -$715.0K | -$901.0K | -$647.0K |
| Investing Cash Flow * | $263.0K | -$180.0K | $772.0K | $63.0K | $479.0K | -$334.0K | -$2.4M | -$595.0K | $33.0K | -$340.0K | -$972.0K | $3.2M | $190.0K | $77.0K | -$240.0K | $0.00 |
| Operating Cash Flow * | -$1.5M | -$891.0K | -$1.4M | $174.0K | $1.1M | $1.5M | $2.3M | $2.3M | $1.9M | $1.2M | $951.0K | -$980.0K | $861.0K | $648.0K | $1.3M | $715.0K |
| Increase Decrease In Other Current Assets | -$35.0K | $43.0K | -$47.0K | -$34.0K | $6.0K | -$178.0K | $87.0K | -$4.0K | -$27.0K | $26.0K | $42.0K | -$3.0K | $26.0K | -$12.0K | $32.0K | $14.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $239.0K | -$27.0K | -$83.0K | -$1.0K | -$85.0K | $43.0K | -$81.0K | $122.0K | $6.0K | $26.0K | -$58.0K | $87.0K | $44.0K | -$89.0K | $46.0K | $11.0K |
| Increase Decrease In Accounts Receivable | $0.00 | $0.00 | -$346.0K | -$10.0K | $38.0K | -$449.0K | -$124.0K | $265.0K | $349.0K | $277.0K | -$7.0K | -$306.0K | -$108.0K | $141.0K | $232.0K | |
| Payments To Acquire Businesses And Interest In Affiliates | $2.0K | $0.00 | $125.0K | $25.0K | $4.0K | $20.0K | $5.0K | $6.0K | $0.00 | $50.0K | $0.00 | $245.0K | $240.0K | $0.00 | ||
| Depreciation Depletion And Amortization | $0.00 | $983.0K | $1.1M | $1.0M | $935.0K | $672.0K | $0.00 | $426.0K | $661.0K | $906.0K | $780.0K | |||||
| Increase Decrease In Due From Related Parties | $0.00 | -$1.0K | $60.0K | -$313.0K | $0.00 | -$34.0K | $138.0K | $0.00 | $0.00 | |||||||
| Payments For Advance To Affiliate | $5.0K | $604.0K | $744.0K | $491.0K | $459.0K | $1.6M | $1.6M | $593.0K | $0.00 | |||||||
| Increase Decrease In Operating Lease Right Of Use Liability | $23.0K | $43.0K | $40.0K | $36.0K | $34.0K | $0.00 | ||||||||||
| Payments For Proceeds From Loans Receivable | $0.00 | -$69.0K | -$274.0K | -$22.0K | -$175.0K | -$434.0K | $436.0K | |||||||||
| Increase Decrease In Income Taxes | -$168.0K | -$5.0K | -$243.0K | $303.0K | -$109.0K | |||||||||||
| Share Based Compensation | $0.00 | $2.0K | $0.00 | $2.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $474.0K | $1.7M | $0.00 | $0.00 | -$89.0K | -$370.0K | -$318.0K | -$257.0K | -$250.0K | -$292.0K | -$147.0K | $462.0K | -$2.3M | ||
| Investing Cash Flow * | -$515.0K | $0.00 | -$126.0K | -$184.0K | $388.0K | $17.0K | -$228.0K | -$820.0K | -$58.0K | -$24.0K | -$61.0K | $53.0K | $3.0M | ||
| Operating Cash Flow * | -$297.0K | -$461.0K | -$130.0K | -$336.0K | $214.0K | $752.0K | $454.0K | $659.0K | $1.8M | $728.0K | $259.0K | -$232.0K | -$242.0K | $344.0K | $148.0K |
| Increase Decrease In Other Current Assets | $5.0K | -$5.0K | $1.0K | -$18.0K | -$19.0K | -$6.0K | -$34.0K | $184.0K | -$9.0K | -$16.0K | -$22.0K | -$3.0K | $14.0K | $12.0K | $63.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$44.0K | $16.0K | -$20.0K | $8.0K | -$4.0K | $13.0K | $24.0K | -$100.0K | $94.0K | $32.0K | $18.0K | $37.0K | $30.0K | $68.0K | -$54.0K |
| Increase Decrease In Accounts Receivable | $0.00 | $482.0K | $40.0K | $474.0K | $36.0K | -$376.0K | $102.0K | $361.0K | $0.00 | $0.00 | -$111.0K | $73.0K | |||
| Payments To Acquire Businesses And Interest In Affiliates | $0.00 | $2.0K | $0.00 | $36.0K | $0.00 | $28.0K | $0.00 | ||||||||
| Depreciation Depletion And Amortization | $0.00 | $285.0K | $282.0K | $235.0K | $238.0K | $0.00 | $0.00 | $128.0K | $323.0K | ||||||
| Increase Decrease In Due From Related Parties | $0.00 | $3.0K | $0.00 | $0.00 | $21.0K | $24.0K | $61.0K | -$198.0K | $298.0K | $26.0K | $0.00 | ||||
| Payments For Advance To Affiliate | $0.00 | $126.0K | $182.0K | $144.0K | $172.0K | $430.0K | $820.0K | $37.0K | |||||||
| Increase Decrease In Operating Lease Right Of Use Liability | $4.0K | $11.0K | $10.0K | $10.0K | $8.0K | $9.0K | $0.00 | ||||||||
| Payments For Proceeds From Loans Receivable | $0.00 | $0.00 | $0.00 | -$9.0K | $0.00 | ||||||||||
| Increase Decrease In Income Taxes | $0.00 | -$166.0K | -$1.0K | -$11.0K | $252.0K | $252.0K | |||||||||
| Share Based Compensation |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.17 | -$0.17 | -$0.11 | $0.07 | $0.02 | -$0.05 | $0.07 | $0.07 | $0.05 | $0.07 | -$0.09 | $0.09 | $0.00 | $0.06 | $0.01 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.7M | |||||
| Common Stock Shares Outstanding | 9.3M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.7M | ||
| Common Stock Shares Issued | 9.3M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.7M | ||
| Common Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 250.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Earnings Per Share Basic | $-0.13 | $-0.09 | $-0.09 | $-0.11 | $0.07 | |||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 15.4M | 9.3M | 7.8M | 7.8M | 7.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 | Q1 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.03 | -$0.02 | -$0.05 | -$0.01 | -$0.04 | -$0.14 | -$0.05 | -$0.05 | -$0.08 | $0.04 | $0.02 | $0.01 | $0.04 | $0.01 | -$0.01 | $0.02 | -$0.02 | $0.01 | $0.01 | $0.00 | $0.02 | $0.03 | $0.02 | $0.02 | $0.03 | $0.01 | $0.00 | $0.01 | $0.03 | $0.03 | -$0.01 | -$0.01 | -$0.02 | -$0.02 | $0.07 | $0.02 | $0.00 | $0.01 | $0.02 | -$0.02 | $0.01 | -$0.01 | $0.01 | $0.01 | $0.05 | -$0.01 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.7M | 7.7M | |||||||||||||||||||||
| Common Stock Shares Outstanding | 21.9M | 21.4M | 21.4M | 20.0M | 17.4M | 13.5M | 9.3M | 9.3M | 7.9M | 7.9M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | |||||||||||||||
| Common Stock Shares Issued | 21.9M | 21.4M | 21.4M | 20.0M | 17.4M | 13.5M | 9.3M | 7.9M | 7.9M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | ||||||||||||||||
| Common Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | ||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||||||||||||||
| Earnings Per Share Basic | $-0.05 | $-0.02 | $-0.02 | $-0.02 | $-0.03 | $-0.03 | $-0.02 | $-0.05 | $-0.01 | $-0.04 | $-0.14 | $-0.05 | $-0.05 | $-0.08 | $0.04 | $0.02 | $0.01 | $0.04 | |||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 21.7M | 21.4M | 21.1M | 17.0M | 13.5M | 11.9M | 7.9M | 7.9M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M | 7.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Care Organization Expenses Net | $0.00 | $86.0K | $361.0K | $350.0K | $1.3M | $1.5M | $1.3M | $1.2M | $692.0K | $0.00 | $675.0K | $884.0K | $603.0K | $411.0K | ||
| Investment Income Interest | $0.00 | $3.0K | $6.0K | $70.0K | $7.0K | $5.0K | $0.00 | $0.00 | $11.0K | $29.0K | $12.0K | $5.0K | $5.0K | |||
| Amount Of Guarantee Obligations Noncurrent | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $15.0K | ||||||||
| Due From Related Parties Current | $0.00 | $1.1M | $169.0K | $7.0K | $21.0K | $8.0K | $316.0K | $292.0K | $208.0K | $70.0K | ||||||
| Interest Paid Net | $0.00 | $2.0K | $0.00 | $3.0K | $25.0K | $94.0K | $122.0K | $143.0K | $172.0K | |||||||
| Asset Retirement Obligations Noncurrent | $0.00 | $517.0K | $491.0K | $466.0K | $431.0K | $0.00 | $0.00 | $100.0K | $200.0K | |||||||
| Gamma Knife Net | $0.00 | $2.7M | $3.5M | $3.3M | $4.0M | $0.00 | $0.00 | $2.2M | $3.0M | |||||||
| Interest Paid | $172.0K | $189.0K | $128.0K | $15.0K | $199.0K | -$177.0K | -$401.0K | -$279.0K | ||||||||
| Asset Retirement Obligation Accretion Expense | $0.00 | $20.0K | $26.0K | $25.0K | $35.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Care Organization Expenses Net | $0.00 | $0.00 | $0.00 | $86.0K | $81.0K | $116.0K | $79.0K | $79.0K | $84.0K | $86.0K | $506.0K | $378.0K | $378.0K | $352.0K | $356.0K | $368.0K | $321.0K | $288.0K | $324.0K | $314.0K | $306.0K | $255.0K | $203.0K | $204.0K | $0.00 | $0.00 | $0.00 | $0.00 | $187.0K | $220.0K | $206.0K | $277.0K | $149.0K | $179.0K | $128.0K | |||||||
| Investment Income Interest | $44.0K | $43.0K | $39.0K | $46.0K | $3.0K | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.0K | $3.0K | $9.0K | $4.0K | $1.0K | $7.0K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Amount Of Guarantee Obligations Noncurrent | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | |||||||||||||||||
| Due From Related Parties Current | $0.00 | $0.00 | $1.2M | $1.1M | $998.0K | $959.0K | $22.0K | $28.0K | $28.0K | $0.00 | $0.00 | $45.0K | $53.0K | $45.0K | $32.0K | $14.0K | $0.00 | $117.0K | $492.0K | $514.0K | $590.0K | $203.0K | $177.0K | $298.0K | $110.0K | |||||||||||||||||
| Interest Paid Net | $0.00 | $1.0K | $2.0K | $2.0K | $11.0K | $32.0K | $35.0K | $40.0K | ||||||||||||||||||||||||||||||||||
| Asset Retirement Obligations Noncurrent | $530.0K | $524.0K | $510.0K | $504.0K | $497.0K | $484.0K | $478.0K | $472.0K | $460.0K | $454.0K | $448.0K | $431.0K | $431.0K | $100.0K | $100.0K | $100.0K | $100.0K | |||||||||||||||||||||||||
| Gamma Knife Net | $3.3M | $2.3M | $2.5M | $2.9M | $3.1M | $3.3M | $3.7M | $3.0M | $3.1M | $3.5M | $3.6M | $3.8M | $3.8M | $3.7M | $1.9M | $2.0M | $2.1M | $2.5M | ||||||||||||||||||||||||
| Interest Paid | $40.0K | $41.0K | $54.0K | $13.0K | $0.00 | $59.0K | -$84.0K | |||||||||||||||||||||||||||||||||||
| Asset Retirement Obligation Accretion Expense | $0.00 | $7.0K | $6.0K | $6.0K | $17.0K | $0.00 |
Most recent annual filing with the SEC: April 2, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.